Toastman: I think positive price action is to do with the earlier report that Isonea will be added to the All Ordinaries Index on 24 March which (I think) means that ISN is one of the top 500 Australian companies by market cap.
Some funds might be required to buy some ISN shares for their portfolio. If not for the last 3 month fiasco we might have seen the stock being added to the ASX300.
Hopefully we have the bottom in place & can build from here. On a bit of positive momentum we could easily rally into the mid 30's for starters.
Then it would be nice to see some positive announcements in relation to the statement made recently : From p.5 of the most recent Director's Report "Discussions with pharmacy chains and health benefit funds are well underway." I imagine discussions with benefit funds relates to patient reimbursements. I think it would be a major step forward if the company managed to secure some form of reimbursement.
They also make comment about pilot testing in two countries. Are they talking about the U.K. or N.Z. or some other country? I would love to see a move into the U.K.
ISN Price at posting:
25.0¢ Sentiment: ST Buy Disclosure: Held